Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Sustained-release formulations of analgesic drugs are promising alternatives to repeated drug injections. Here, we compared a sustained-release formulation of buprenorphine (SB, 2.2 mg/kg) with a standard protocol of three injections of buprenorphine (Temgesic, 0.1 mg/kg/8 h) in mice. Buprenorphine ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1177/0023677214562849
データ提供:米国国立医学図書館(NLM)
Buprenorphine for Pain Relief: Comparing Delivery Methods
Sustained-release formulations of analgesic drugs offer a promising alternative to repeated injections. This study compares a sustained-release formulation of buprenorphine (SB) to a standard protocol of three injections of buprenorphine (Temgesic) in mice. The research aims to evaluate the efficacy and duration of action of these two delivery methods, assessing their impact on pain relief and potential side effects. The authors meticulously analyze the serum concentrations, analgesic action, and behavioral outcomes associated with both protocols, providing valuable insights into the optimal approach for managing pain in animal models.Navigating the Complexities of Pain Management
This research highlights the importance of considering different delivery methods for analgesic drugs, exploring the trade-offs between sustained-release formulations and repeated injections. The study provides valuable insights into the efficacy and duration of action of buprenorphine, suggesting that sustained-release formulations may offer a more effective and less stressful approach to managing pain in animal models.Sustained-Release Buprenorphine: A Promising Avenue for Pain Management
This research underscores the potential of sustained-release buprenorphine for managing pain in animal models. The study provides evidence suggesting that SB offers a longer duration of action and may minimize the need for repeated injections, potentially reducing stress and improving patient comfort.Dr. Camel's Conclusion
Imagine a desert caravan traversing a challenging terrain. This research explores two approaches to managing pain, comparing a sustained-release formulation of buprenorphine to a standard protocol of repeated injections. The findings suggest that the sustained-release formulation may offer a smoother and more effective journey for those navigating the demanding landscape of pain management.Date :
- Date Completed 2016-05-13
- Date Revised 2015-06-27
Further Info :
Related Literature
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.